Copyright Us Weekly
In the world of celebrity weight loss journeys, several stars are getting real about their experiences with GLP-1 medications like Ozempic. Dolores Catania faced challenges when Mounjaro stopped working, leading to a 20-pound gain as she searched for the right wellness solution. Amanda Bynes, on the other hand, is hopeful that Ozempic will help her drop over 40 pounds, as she openly shares updates on her progress. Meanwhile, Sacha Baron Cohen credits a mix of Ozempic, private chefs and personal training for his stunning transformation ahead of a new movie role. The conversation around these medications isn’t all smooth sailing, though. Plastic surgeon Dr. Terry Dubrow has been vocal about the safety of such treatments, controversially comparing them to Tylenol. Following similar paths, Serena Williams celebrates a 31-pound weight loss, thanking the GLP-1 for helping her feel healthier and more energetic post-pregnancy. Chrissy Teigen, meanwhile, shared her emotional journey with Ozempic following her tragic pregnancy loss, describing how the drug helped both physically and mentally. Lastly, The Secret Lives of Mormon Wives star Whitney Leavitt cleared rumors she was back on Ozempic, affirming she’s focused on other health strategies, including counting macros and exercise, after experiencing unwelcome side effects from the injections previously. NO. 1: DOLORES CATANIA GAINED 20 LBS AFTER MOUNJARO ‘STOPPED WORKING’ NO. 2: AMANDA BYNES IS GOING ON OZEMPIC, HOPES TO LOSE MORE THAN 40 LBS NO. 3: SACHA BARON COHEN ADMITS TO USING OZEMPIC FOR HIS BODY TRANSFORMATION NO. 4: ‘BOTCHED’ DR. TERRY DUBROW BELIEVES TYLENOL IS ‘MORE DANGEROUS’ THAN OZEMPIC NO. 5: SERENA WILLIAMS REVEALS 31-POUND WEIGHT LOSS FROM GLP-1 NO. 6: CHRISSY TEIGEN OPENS UP ABOUT TAKING OZEMPIC AFTER LOSS OF SON JACK NO. 7: SECRET LIVES OF MORMON WIVES' WHITNEY LEAVITT ADDRESSES OZEMPIC SPECULATION This report was produced with the help of AI tools, which summarized previous stories reported and written by McClatchy journalists. It was edited by journalists from Us Weekly.
